FDA Approves Akeega as the First Precision Therapy for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer

Dec 15, 2025 - 06:00
 0  1
HORSHAM, PA, December 12, 2025/PRNewswire/ – Johnson & Johnson (NYSE:JNJ) announced today the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Akeega (niraparib and abiraterone acetate...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0